Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kimberly Perry"'
Publikováno v:
Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 66:1240-1244
The goal of the present study was to examine how naturalistic interruptions (head turns) and cueing affect change detection within dynamic scenes. Based on the memory for goals (Altmann & Trafton, 2002) and visual memory theories (Hollingsworth & Hen
Autor:
Kimberly Perry, Delores E. McNair
Publikováno v:
New Directions for Community Colleges. 2020:35-42
Publikováno v:
Tetrahedron Lett
The revival of peptide-based drugs has led to the increasing demand for the development of large-scale synthesis of these complex molecules. To meet this demand, the use of mercapto-functionalized polyhedral oligomeric silsesquioxane (POSS-SH) as a s
Publikováno v:
Notes from the Field. 53
This paper emerges from the particular field experiences of three “settler” colleagues working in a teacher education program, each of whom found that their personal and professional relationships with First Nations, Metís, and Inuit people had
Autor:
Samantha Bock, Morgan Yount, Sara Ankarstad, Janice E. Brunstrom-Hernandez, Sandy A. Ross, Jennifer Miros, Britta Orso, Kimberly Perry
Publikováno v:
American journal of physical medicinerehabilitation. 96(12)
Objective Children with cerebral palsy may benefit from maintaining a high level of physical fitness similar to typically developing children especially in terms of long-term physical performance, although in practice this is often difficult. The pur
Autor:
Howard L. McLeod, David O. Meltzer, Taimour Y. Langaee, Mohamed H. Shahin, Kimberly Perry, Sherief Khalifa, Shitalben R. Patel, Julie A. Johnson, Anne Misher, Larisa H. Cavallari, Minoli A. Perera
Publikováno v:
Thrombosis and Haemostasis. 109:1045-1050
SummaryThe VKORC1 Asp36Tyr single nucleotide polymorphism (SNP) is one of the most promising predictors of high warfarin dose, but data on its population prevalence is incomplete. We determined the frequency of this SNP in participants from seven cou
Autor:
Robert Hartlage, Brock A. Peters, Igor Nazarenko, Jonathan Baccash, Calvin Kong, Vitali Karpinchyk, Andres Fernandez, Abraham M. Rosenbaum, Ryan J. Cedeno, Paolo Carnevali, Celeste E. McBride, Norman L. Burns, Shaunak Roy, Karen W. Shannon, George M. Church, Snezana Drmanac, Daniel F. Chernikoff, Radoje Drmanac, Geoffrey B. Nilsen, Claudia Richter, Coleen R. Hacker, Jay Shafto, William C. Banyai, Kaliprasad Pothuraju, Helena Perazich, Bruce L. Martin, Dennis G. Ballinger, Benjamin Curson, Linsu Chen, Brian Hauser, Steve Huang, Alexander Wait Zaranek, Anushka Brownley, Dylan Vu, Matt Morenzoni, Andrew B. Sparks, Matthew J. Callow, Alex Cheung, Clifford Reid, Adam P. Borcherding, George Yeung, Xiaodi Wu, Catherine Le, Tom Landers, Aaron L. Halpern, Bahram G. Kermani, Kimberly Perry, Arnold R. Oliphant, Mark Koenig, Charit L. Pethiyagoda, Michel Sun, Joseph V. Thakuria, Conrad G. Sheppy, Anne Tran, Robert E. Morey, Fredrik A. Dahl, Krishna Pant, Karl Mutch, Bryan Staker, Joe Peterson, Jessica Ebert, Yuan Jiang, Jia Liu, Razvan Chirita, Uladzislau Sharanhovich
Publikováno v:
Science. 327:78-81
Toward $1000 Genomes The ability to generate human genome sequence data that is complete, accurate, and inexpensive is a necessary prerequisite to perform genome-wide disease association studies. Drmanac et al. (p. 78 , published online 5 November) p
Autor:
Marcin Paduch, Tet Matsuguchi, Debbie Dong, Jason Moffat, Stephen Anderson, Susanne Gräslund, Jay S Goodman, Svitlana Usatyuk, Shane Miersch, Anthony A. Kossiakoff, Judy Luke, Carly Griffin, Nan Zhong, Kimberly Perry, Vince Lu, Zhijian Li, Robert J. Hoey, Shohei Koide, Allison K. Doak, Franco J. Vizeacoumar, James A. Wells, Annika Sääf, Sachdev S. Sidhu, Michael Hornsby, Karolina Wypisniak, Elliot Campbell, Daniel King, William I. Thomas, Brian Lee, Darson Lai
Publikováno v:
Molecular & Cellular Proteomics : MCP
Antibodies are key reagents in biology and medicine, but commercial sources are rarely recombinant and thus do not provide a permanent and renewable resource. Here, we describe an industrialized platform to generate antigens and validated recombinant